Related Experiment Video
Updated: May 24, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.2K
Does Excessive Tonic Inhibition Cause Unstable Feedback in Parkinson's Disease?
Summary
Parkinson's disease involves excessive brain inhibition, potentially causing both movement deficits and tremor. This study reveals how altered neural feedback mechanisms create unstable motor control, unifying symptoms of Parkinson's disease.
Area of Science:
- Neuroscience
- Motor Control
- Computational Biology
Background:
- Parkinson's disease (PD) is linked to dopamine deficiency in basal ganglia, leading to excessive thalamic inhibition.
- This excessive inhibition explains reduced motor vigor but its role in tremor is unclear.
Purpose of the Study:
- To investigate how altered inhibition in Parkinson's disease affects closed-loop motor control characteristics.
- To determine the mechanisms by which excessive tonic inhibition could generate tremor.
Main Methods:
- Utilized single-neuron simulations to model the effects of increased tonic inhibition.
- Adjusted membrane time constants to establish neural firing rate and timing characteristics.
- Analyzed closed-loop dynamics and forward models to identify feedback instability mechanisms.
Main Results:
- Simulations demonstrated that increased tonic inhibition can lead to unstable feedback through information delay or signal decrease.
- These instabilities create a mismatch between closed-loop dynamics and predictive forward models.
- The findings suggest a unifying mechanism for both motor inhibition and excitatory symptoms in Parkinson's disease.
Conclusions:
- Excessive tonic inhibition in Parkinson's disease can destabilize neural feedback loops.
- This unstable feedback provides a potential unifying pathophysiology for diverse motor symptoms in Parkinson's disease, including tremor.
Related Concept Videos
Parkinson's Disease: Overview
419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419
Parkinson's Disease: Treatment
182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Excitatory and Inhibitory Effects of Neurotransmitters
9.7K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.7K
Feedback Inhibition
53.6K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.6K
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K

